26 – 30 May 2025 – RGCC recently had the pleasure of hosting 14 esteemed oncologists and healthcare practitioners, longstanding collaborators and key contributors to our shared mission, in an immersive visit across our laboratories in Switzerland, Germany, and Greece.
The multi-day initiative was designed to provide a comprehensive look into RGCC’s cutting-edge technologies and methodologies. During their visit, the participants were given exclusive access to our research facilities, where they explored the scientific innovations driving our work in precision medicine and cancer diagnostics.
“This initiative is part of our ongoing commitment to bridge the gap between laboratory research and real-world clinical practice,” said Dr. Ioannis Papasotiriou, founder and scientific director of RGCC.
RGCC extends its sincere gratitude to all the participants for their continued trust and collaboration. Together, we are pushing the boundaries of what is possible in oncology and beyond.